1. Biomodulation of 5-fluorouracil by interferon-α in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase

   • Tatsuo Morita
   • Akihiko Tokue

   ORIGINAL ARTICLE Pages: 91 - 96

2. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)uracil

   • Satoshi Takatori
   • Hiroshi Kanda
   • Takuma Sasaki

   ORIGINAL ARTICLE Pages: 97 - 104

3. Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay

   • Carolyn D. Britten
   • Elzbieta Izbicka
   • Daniel D. Von Hoff

   ORIGINAL ARTICLE Pages: 105 - 110

4. Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat Enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery

   • Alexander L. Vahrmeijer
   • Jan Hein van Dierendonck
   • Gerard J. Mulder

   ORIGINAL ARTICLE Pages: 111 - 116

5. Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines

   • Sandrine Faivre
   • Eric Raymond
   • Esteban Cvitkovic

   ORIGINAL ARTICLE Pages: 117 - 123

6. Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes

   • Winnie Yeo
   • Kenneth K. Chan
   • Philip J. Johnson

   ORIGINAL ARTICLE Pages: 124 - 130

7. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines

   • Hayley M. McDaid
   • Samit K. Bhattacharya
   • Samuel J. Danishefsky

   ORIGINAL ARTICLE Pages: 131 - 137

8. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel

   • Paola Della Torre
   • Anthony R. Imondi
   • Guy Mazué

   ORIGINAL ARTICLE Pages: 138 - 142

9. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

   • Maya Gurnani
   • Philip Lipari
   • Loretta L. Nielsen

   ORIGINAL ARTICLE Pages: 143 - 151

10. Immunosuppressant inhibition of P-glycoprotein function is independent of drug-induced suppression of peptide-prolyl isomerase and calcineurin activity

    • Katrina L. Mealey
    • Rola Barhoumi
    • Deborah T. Kochevar

    ORIGINAL ARTICLE Pages: 152 - 158

11. Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

    • Alfredo Falcone
    • Giacomo Allegrini
    • Pierfranco Conte

    CLINICAL TRIAL REPORT Pages: 159 - 163

12. Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptake

    • Veena M. Vasandani
    • Jennifer A. Burris
    • Cynthia Sung

    SHORT COMMUNICATION Pages: 164 - 169

13. Increased urinary losses of carnitine during ifosfamide chemotherapy

    • Niklaus P. Marthaler
    • Theresa Visarius
    • Bernhard H. Lauterburg

    SHORT COMMUNICATION Pages: 170 - 172

14. Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin

    • Massimo Zucchetti
    • Amerigo Boiardi
    • Maurizio D'Incalci

    SHORT COMMUNICATION Pages: 173 - 176